Abstract:Objective To determine whether osteocalcin and estrogen existed in synovial fluid and to study the relationship between the synovial osteocalcin and estradiol levels and temporomandibular disorders.Methods Synovial fluid was obtained from 31 temporomandibular joints (TMJs) of the patients with TMD for osteocalcin,and 42 TMJs for estradiol detection respectively.All patients were diagnosed as internal derangement (ID) or osteoarthrosis by raiographs and clinical examination.7 synovial fluid samples of healthy volunteers served as normal control.The concentration of osteocalcin and estradiol in synovial fluid was determined by radioimmunoassay (RIA).The association of synovial osteocallcin and estradiol levels with TMD and their clinical significances were also discussed.Results Synovial fluid osteocalcin was found in all patients and controls.There was no significant difference in synovial osteocalcin level between ID and normal control (P＞0.05),but the concentration of synovial osteocalcin was significant higher in OA than that of the normal control and ID (P＜0.05).Synovial fluid E2 was found in all patients and controls.The concentration of synovial E2 was significant higher in ID and OA than that of normal control,but there was no significant difference in synovial E2 level between ID and OA.Synovial E2 level was much higher in TMJs with osteosclerotic change and no difference between male and female patients with TMD.Conclusion These results suggest that estrogen could be involved in the pathogenesis and development of TMD.High level of synovial estradiol may contribute to osteoselerotic change of TMJs.Meanwhile,TMJOA may relate to local increase of bone turnover and abnormalities of bone metabolism.Quantification of osteocalcin in synovial fluid holds promise as a useful means of assesing the alteration of bone at the molecular level in the patients with TMD.

Interleukin-6 family of cytokines as biochemical markers of osseous changes in the temporomandibular joint disorders

Interleukin-6 in Synovial Fluid and HLA-DR Expression in Synovium from Patients with Temporomandibular Disorders.

[Interleukin-6 Activity in Synovial Fluids of Temporomandibular Joint Distrubance Syndrome].

Osteocalcin and Estradiol in Synovial Fluid of the Patients with Temporomandibular Disorders

Elevated Leptin Levels in Temporomandibular Joint Osteoarthritis Promote Proinflammatory Cytokine IL-6 Expression in Synovial Fibroblasts.

The Role of Interleukin-6 and TGF-β1 in the Pathogenesis of the Osteoarthritis of Knee

Clinical Significance of Expression of MMP-3 and MMP-9 in Joint Fluid of Patients with Temporomandibular Disorder

A comparative analysis of NLRP3-related inflammatory mediators in synovial fluid in temporomandibular joint osteoarthritis and internal derangement

Expression of Adamts-5 and Timp-3 in the Condylar Cartilage of Rats Induced by Experimentally Created Osteoarthritis

Metabolic profiling of synovial fluid in human temporomandibular joint osteoarthritis

Matrix metalloproteinase-3 and nitric oxide in synovial fluid from temporomandibular jionts

Proinflammatory cytokines in temporomandibular joint synovial fluid before and after arthrocentesis

Suberoylanilide Hydroxamic Acid Attenuates Interleukin-1β-Induced Interleukin-6 Upregulation by Inhibiting the Microtubule Affinity-Regulating Kinase 4/Nuclear Factor-κB Pathway in Synovium-Derived Mesenchymal Stem Cells from the Temporomandibular Joint

Expression of inflammatory substances in the synovial fluid of patients with knee osteoarthritis

[Alteration of the Expression of Cartilage Matrix Molecule in the Cartilage by the Chondrocytes from Rabbit Temporomandibular Joint with Experimental Osteoarthritis and Its Response to Interleukin-1 Beta].

Evaluation of IL-1β and CRP mRNA expression levels by RT-PCR in postorthodontic treatment patients with temporomandibular joint disorders: a cross-sectional Study

Tumor necrosis factor in synovial fluids of temporomandibular joint dysfunction syndrome]

Quantitative bone imaging biomarkers to diagnose temporomandibular joint osteoarthritis

Molecular changes in peripheral blood involving osteoarthritic joint remodelling

Association of HMGB1 levels in synovial fluid with the severity of temporomandibular joint osteoarthritis

Author Response for "increased Chemokine RANTES in Synovial Fluid and Its Role in Early‐stage Degenerative Temporomandibular Joint Disease"